The world needs faster, better, more affordable access to high quality care.
Our Care Delivery Model makes this possible through clinical excellence, effective management of innovative medical and digital technology, a culture of continuous improvement, professional development of our people and an outstanding patient experience.
Integrated Clinical Governance Model
Clinical excellence is at the heart of everything we do. That is why we have an exceptional clinical governance team overseeing all medical care, driving subspecialty expertise and fostering a culture of continuous quality improvement.
The 'Affidea Standard' defines the best practice across our countries, with further protocols on health and safety, radiation protection and MR.
The Affidea Imaging Medical Council shares best practice across all clinical functions with separate steering groups for cancer treatment and nuclear medicine.
Our Medical Advisory Boards comprise internationally renowned radiologists and cancer care specialists from across Europe who provide guidance to the company. Six Leading European radiology experts (four previous Presidents of the European Society of Radiology) are part of our Medical Advisory Board, providing international leadership.
Each country in the Affidea network has local committees which mirror the central clinical governance structure– a medical council, radiation protection and MR safety groups. These bodies are in place to ensure every patient finds the same high standards of quality and safety regardless of Affidea clinic. Because nothing is more important than health.
Patient safety is our prime concern and is continually monitored by our global Affidea Incident Management System (AIMS). AIMS enables us to capture and, most importantly, learn from events. We also benefit from witnessing and recording examples of good practice achieved by staff members in the workplace.
The Dose Excellence Program (DEP) is the largest global dose optimisation program for computed tomography (CT), recognised by the European Society of Radiology.
We have developed a standardised set of CT protocols to take comparable images across our network allowing us to optimise the radiation dose patients receive while ensuring appropriate image quality. In this respect, we have achieved an average of 40% reduction of the dose level in CT scans across our network, in the same maintaining diagnostic confidence.
This care standardisation program enables Affidea to be the most represented provider of imaging services on the Eurosafe 'Wall of Stars', celebrating best practice in radiation protection.
Our Dose Excellence Program received privileged recognition on the EuroSafe Imaging Wall of Stars, the European Society of Radiology’s initiative to promote quality and safety in medical imaging
Magnetic Resonance Imaging (MRI) is one of the best ways to provide diagnostic imaging but traditionally suffers from the variability in the way images are taken and the lack of speed in acquiring the images. The Affidea MRI Excellence Program (MREP) standardises the way MRI is performed across the network.
We have developed software that remotely monitors the MRI machines, feeding back on the standard to which the protocols are followed, time taken for each scan and image quality produced. We are able to learn from the centres providing the best service and reproduce this across our countries in a structured manner. This MRI optimisation program is the largest of its kind globally.
Research and development are critical components to Affidea's long term strategy and are essential for us to stay at the forefront of clinical practice. We partner with, many of Europe's leading academics from University College London and we provide services to academic institutions and we support research across many countries including the Champalimaud Foundation in Portugal.
The Affidea Innovation Fund provides an opportunity for doctors within our network to apply for pump-priming grants for clinical and commercial studies. If successful, they may receive external grant funding or further commercial support from Affidea.
